月見草油 Evening Primrose Oil

INT-evening-primrose-oil-001 3 個適應症被研究
C 2 U 1

適應症與證據等級

法規與權威立場 (L4)

L4a · US FDA
立場:cautious
In 1985, FDA issued a series of Import Alerts announcing that Evening Primrose Oil could not be sold lawfully in the United States without FDA approval, that the substance did not have FDA approval, and that all import shipment of evening primrose oil offered for entry into the U.S. were to be detained by Customs.
來源 ↗
L4b · EU EFSA
立場:against
L4c · UK NHS
立場:against
[NHS.uk, menopause herbal remedies page] Evening primrose oil is listed among herbal remedies "sometimes taken for menopause symptoms"; the page warns that such herbal remedies "are not tested and regulated in the same way as medicines such as hormone replacement therapy (HRT), so it's not known how safe and effective they are", may "cause unpleasant side effects", and that "the quality, purity…
來源 ↗
L4d · TW TFDA / 衛福部
立場:neutral
在台灣食品法規下,月見草油不得標示療效,也不得聲稱療效。除健康食品外,一般食品均不得宣稱保健功效。
來源 ↗
L4e · WHO
立場:not_addressed

市場與行銷 (L10)

L10a · TW Market Channels
月見草油 GLA 女性保健
L10b · TW Legal Identity (TFDA)
月見草油為由種子製成;草、木本植物類可供直接食用
L10c · TW Community (PTT/Dcard/Mobile01)
挺立只是補鈣啊,跟更年期症狀沒有什麼關係